Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 5/20 | 0.39 |
| ▸ | HDAC2 | Q92769 | 5/20 | 0.39 |
| ▸ | HDAC3 | O15379 | 4/20 | 0.39 |
| ▸ | HDAC8 | Q9BY41 | 4/20 | 0.39 |
| ▸ | FFAR3 | O14843 | 3/20 | 0.39 |
| ▸ | CES2 | O00748 | 1/20 | 0.35 |
| ▸ | CES1 | P23141 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.32 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.30 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.30 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.30 |
| ▸ | HTR2A | P28223 | 1/20 | 0.30 |
| ▸ | HTR2C | P28335 | 1/20 | 0.30 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.30 |
| ▸ | HRH1 | P35367 | 1/20 | 0.30 |
| ▸ | DRD3 | P35462 | 1/20 | 0.30 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL148170 | 1.00 | HDAC1 (0.39) | HDAC1HDAC2HDAC3HDAC8FFAR3 | |
| SCHEMBL147780 | 0.88 | CES1 (0.40) | CES2CES1TSHRALDH1A1TDP1 | |
| SCHEMBL147781 | 0.88 | CES1 (0.40) | CES2CES1TSHRALDH1A1TDP1 | |
| SCHEMBL905414 | 0.88 | CES1 (0.40) | CES2CES1TSHRALDH1A1TDP1 | |
| SCHEMBL1275312 | 0.86 | AKR1B1 (0.45) | CES2CES1TSHRALDH1A1TDP1 | |
| SCHEMBL1275314 | 0.86 | AKR1B1 (0.45) | CES2CES1TSHRALDH1A1TDP1 | |
| SCHEMBL423101 | 0.84 | GPR84 (0.47) | CES2CES1TSHRALDH1A1TDP1 | |
| SCHEMBL423100 | 0.84 | GPR84 (0.47) | CES2CES1TSHRALDH1A1TDP1 | |
| SCHEMBL142753 | 0.84 | GPR84 (0.47) | CES2CES1TSHRALDH1A1TDP1 | |
| SCHEMBL1602953 | 0.84 | GPR84 (0.47) | CES2CES1TSHRALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9752049-B2 | Optically transparent, superhydrophobic, biocompatible thin film coatings and methods for producing same | UT-BATTELLE, LLC (US) | 2017-09-05 | — | — | US | claimed |
| EP-1562489-B1 | STABILIZED POLYESTER/CYANOACRYLATE TISSUE ADHESIVE FORMULATION | POLY MED INC (US) | 2016-08-24 | — | — | EP | claimed |
| US-20150232690-A1 | OPTICALLY TRANSPARENT, SUPERHYDROPHOBIC, BIOCOMPATIBLE THIN FILM COATINGS AND METHODS FOR PRODUCING SAME | UT-BATTELLE, LLC (US) | 2015-08-20 | — | — | US | claimed |
| US-20100190924-A1 | POLYMER COMPOSITES AND METHODS FOR PRODUCING THE SAME | UNITED STATES DEPARTMENT OF AGRICULTURE (IL) | 2010-07-29 | — | — | US | claimed |
| WO-2009003197-A1 | POLYMER COMPOSITES AND METHODS FOR PRODUCING THE SAME | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 2008-12-31 | — | — | WO | claimed |
| EP-1360257-B1 | CYANOACRYLATE COMPOSITIONS CURABLE TO FLEXIBLE POLYMERIC MATERIALS | LOCTITE R & D LTD (IE) | 2007-07-25 | — | — | EP | claimed |
| EP-1562489-A4 | STABILIZED POLYESTER/CYANOACRYLATE TISSUE ADHESIVE FORMULATION | POLY MED INC (US) | 2007-01-17 | — | — | EP | claimed |
| US-7083634-B2 | Stabilized polyester/cyanoacrylate tissue adhesive formulation | POLY MED INC (US) | 2006-08-01 | — | — | US | claimed |
| US-6977278-B1 | Cyanoacrylate compositions curable to flexible polymeric materials | LOCTITE (R&D) LTD. (IE) | 2005-12-20 | — | — | US | claimed |
| EP-1562489-A2 | STABILIZED POLYESTER/CYANOACRYLATE TISSUE ADHESIVE FORMULATION | Poly-Med, Inc. (US) | 2005-08-17 | — | — | EP | claimed |
| US-20050042197-A1 | Stabilized polyester/cyanoacrylate tissue adhesive formulation | POLY-MED, INC. | 2005-02-24 | — | — | US | claimed |
| WO-2004045498-A2 | STABILIZED POLYESTER/CYANOACRYLATE TISSUE ADHESIVE FORMULATION | POLY-MED, INC. (US) | 2004-06-03 | — | — | WO | claimed |
| WO-2004024467-A2 | SURFACE-MOUNTING SYSTEM | LOCTITE (R & D) LIMITED (IE) | 2004-03-25 | — | — | WO | claimed |
| EP-1360257-A1 | CYANOACRYLATE COMPOSITIONS CURABLE TO FLEXIBLE POLYMERIC MATERIALS | Loctite (R & D) Limited (IE) | 2003-11-12 | — | — | EP | claimed |
| US-20030069535-A1 | Stabilized polyester/cyanoacrylate tissue adhesive formulation | POLY-MED, INC. | 2003-04-10 | — | — | US | claimed |
| WO-2002053666-A1 | CYANOACRYLATE COMPOSITIONS CURABLE TO FLEXIBLE POLYMERIC MATERIALS | LOCTITE (R & D) LIMITED (IE) | 2002-07-11 | — | — | WO | claimed |
| US-20260112694-A1 | SYSTEM AND METHOD FOR IMPROVED BATTERY STRUCTURAL PROPERTIES | Anthro Energy, Inc. (US) | 2026-04-23 | — | — | US | disclosed |
| US-20250372706-A1 | SYSTEM AND METHOD FOR IMPROVED BATTERY STRUCTURAL PROPERTIES | Anthro Energy, Inc. (US) | 2025-12-04 | — | — | US | disclosed |
| EP-1360257-A1 | CYANOACRYLATE COMPOSITIONS CURABLE TO FLEXIBLE POLYMERIC MATERIALS | Loctite (R & D) Limited (IE) | 2003-11-12 | — | — | EP | disclosed |
| WO-2002053666-A1 | CYANOACRYLATE COMPOSITIONS CURABLE TO FLEXIBLE POLYMERIC MATERIALS | LOCTITE (R & D) LIMITED (IE) | 2002-07-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260112694-A1 | SYSTEM AND METHOD FOR IMPROVED BATTERY STRUCTURAL PROPERTIES | PARG, PUF60, PHOSPHO1 | HDAC1 1228/4885HDAC2 2527/4885HDAC3 2057/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.